In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States.

Liu, Xiaoqiang; Boothe, Dawn M; Jin, Yaping; Thungrat, Kamoltip

Liu, Xiaoqiang; Boothe, Dawn M; Jin, Yaping; Thungrat, Kamoltip.

Affiliation

Liu X; College of Veterinary Medicine, Northwest A&F University, Yangling 712100, Shaanxi, People's Republic of China.

World J Microbiol Biotechnol ; 29(2): 347-54, 2013 Feb.

Article in En | MEDLINE | ID: mdl-23136054

Subject(s)

Anti-Bacterial Agents/pharmacology; Cat Diseases/microbiology; Dog Diseases/microbiology; Escherichia coli Infections/veterinary; Fluoroquinolones/pharmacology; Uropathogenic Escherichia coli/drug effects; Animals; Anti-Bacterial Agents/chemistry; Cat Diseases/drug therapy; Cats; Dog Diseases/drug therapy; Dogs; Drug Resistance, Bacterial; Escherichia coli Infections/drug therapy; Escherichia coli Infections/microbiology; Fluoroquinolones/chemistry; Microbial Sensitivity Tests; Molecular Structure; United States; Uropathogenic Escherichia coli/classification; Uropathogenic Escherichia coli/isolation & purification

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Cat Diseases / Fluoroquinolones / Dog Diseases / Escherichia coli Infections / Uropathogenic Escherichia coli / Anti-Bacterial Agents Country/Region as subject: America do norte Language: En Journal: World J Microbiol Biotechnol Year: 2013 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google